Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Americord is a premier health-tech company specializing in the preservation of umbilical cord blood, cord tissue, and placental tissue. Founded in 2008, the company provides families with high-quality stem cell banking services using its proprietary Cord Blood 2.0 processing technology, which aims to maximize the number of stem cells collected. Americord operates as a private registry, ensuring that stored stem cells are available for personalized medical treatments for the donor or their family members. The company is committed to advancing regenerative medicine by providing access to hematopoietic and mesenchymal stem cells for the treatment of numerous life-threatening conditions. Their services are compliant with FDA regulations and are processed in AABB-accredited laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Americord.